1-5 of 5
Joan Besalduch, MD
Close
Sort by
Journal Articles

NK and T-Cell Status as Well as Their Perforin Expression Is Related to Clinical Severity and Outcome in Difuse Large Cell Lymphoma.

Antonio Gutierrez, MD, Jose Rodriguez, MD, Jordi Martinez, PhD, Carmen Ballester, MD, Catalina Crespi, PhD, Maria Dolores Bea, LT, Juan Carlos Amat, LT, Roberto Villavicencio, LT, Miguel Morey, MD, Maria Antonia Duran, MD, Cristina Linares, MD, Julio Rifa, MD, Antonia Bautista, MD, Oliver Voegler, PhD, Regina Alemany, PhD, Antonia Sampol, MD, Joan Besalduch, MD
Journal: Blood
Blood (2007) 110 (11): 1574.
https://doi.org/10.1182/blood.V110.11.1574.1574
Published: 2007
Journal Articles

Clinical Prognostic Factors in Chemosensitive Multiple Myeloma (MM) Patients Intensified with High Dose Therapy/Stem Cell Support (HDT/SCS): Results of the Spanish Trial (PETHEMA/GEM2000).

María-Victoria Mateos, MD, PhD, Juán-José Lahuerta, MD, PhD, Anna Sureda, MD, PhD, Javier de la Rubia, MD, PhD, Ramón García-Sanz, MD, PhD, Rafael Martínez, MD, PhD, José García-Laraña, MD, PhD, Felipe de Arriba, MD, PhD, Jose-María Ribera, MD, PhD, Miguel-Teodoro Hernández, MD, PhD, Lourdes Escoda, MD, PhD, Dolores Carrera, MD, PhD, Joan Besalduch, MD, PhD, B. Hernández, MD, PhD, P. Fernández, MD, PhD, Joan Blade, MD, PhD, J.F. San Miguel, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 937.
https://doi.org/10.1182/blood.V110.11.937.937
Published: 2007
Journal Articles

Tandem Autologous Transplant Versus Reduced Intensity Conditioned Allogeneic Transplant (Allo-RIC) as Second Intensification in Chemosensitive Patients with Multiple Myeloma (MM) Not Achieving Complete Remission (CR) or Near-CR with a First Autologous Transplant. Results from a Spanish PETHEMA/GEM Study.

Joan Blade, MD, Laura Rosinol, MD, Juan Jose Lahuerta, MD, Anna Sureda, MD, Javier de la Rubia, MD, Jose Garcia-Larana, MD, Miguel Hernandez-Garcia, MD, Belen Hernandez-Ruiz, MD, Jose Antonio Perez-Simon, MD, Jose Luis Bello, MD, Dolores Carrera, MD, Maria Jesus Penarrubia, MD, Eugenia Abella, MD, Angel Leon, MD, Concepcion Poderos, MD, Juan Carlos Garcia-Ruiz, MD, Joan Besalduch, MD, Rafael Martinez-Martinez, MD, Isabel Perez-Fernandez, MD, Paz Ribas, MD, Jesus San Miguel, MD
Journal: Blood
Blood (2007) 110 (11): 729.
https://doi.org/10.1182/blood.V110.11.729.729
Published: 2007
Journal Articles

Computed Tomography (CT) Predicts Response Duration in Patients with Chronic Lymphocytic Leukemia (CLL) in Complete Response (CR) by Conventional, NCI-Working Group, Criteria.

Francesc Bosch, MD, Ana Muntañola, MD, Ana Ferrer, MD, Marcos González, MD, Eva Gine, MD, Eugenia Abella, MD, Santi Gardella, MD, Javier Briones, MD, Eva González-Barca, MD, Lourdes Escoda, MD, Elena Pérez-Ceballos, MD, Antoni Asensi, MD, Maria José Sayas, MD, Joan Besalduch, MD, Emili Montserrat, MD
Journal: Blood
Blood (2006) 108 (11): 2835.
https://doi.org/10.1182/blood.V108.11.2835.2835
Published: 2006
Journal Articles

Comparison of Intensive Chemotherapy (CHT), Allogeneic (ALLO) or Autologous (AUTO) Stem Cell Transplantation (SCT) as Post-Remission Treatment for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL). Final Results of the PETHEMA ALL-93 Trial.

Josep-Maria Ribera, MD, Albert Oriol, MD, Concepcion Bethencourt, MD, Ricardo Parody, MD, Jesus-Maria Hernandez-Rivas, MD, Maria-Jose Moreno, MD, Eloy Del Potro, MD, Mar Tormo, MD, Concepcion Rivas, MD, Joan Besalduch, MD, Miguel-Angel Sanz, MD, Jesus Arias, MD, Javier Fernandez-Calvo, MD, Jose-Maria Moraleda, MD, Javier Bueno, MD, Evarist Feliu, MD, Juan-Jose Ortega, MD
Journal: Blood
Blood (2004) 104 (11): 2731.
https://doi.org/10.1182/blood.V104.11.2731.2731
Published: 2004